Schroder Investment Management Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Schroder Investment Management Group’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-310,499	Closed	-$590K	–	1219
2023 Q4	$590K	Buy	+310,499	New	+$464K	﹤0.01%	1067
2022 Q3	–	Sell	-248,287	Closed	-$2.7M	–	1309
2022 Q2	$2.7M	Buy	248,287 +187,046	+305%	+$2.24M	﹤0.01%	920
2022 Q1	$1.16M	Buy	61,241 +16,617	+37%	+$426K	﹤0.01%	1108
2021 Q4	$919K	Buy	44,624 +22,691	+103%	+$1.36M	﹤0.01%	1046
2021 Q3	$691K	Sell	21,933 -2,581	-11%	-$187K	﹤0.01%	1164
2021 Q2	$2.06M	Buy	+24,514	New	+$1.62M	﹤0.01%	1011

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

EAM

Exome Asset Management New York $162M AUM 259.04% 1-Year Est. Return

EPL

EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Schroder Investment Management Group's NBP Position: Q1 2024 in Review

Schroder Investment Management Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2024, closing a stake of 310,499 shares — an estimated $590K sold.

Schroder Investment Management Group first reported a position in NBP in Q2 2021 and held it in 6 quarters. The position peaked at $2.7M in Q2 2022. 39 funds tracked by Wall St. Rank hold NBP as of Q1 2024.

Schroder Investment Management Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Schroder Investment Management Group sold 310,499 NovaBridge Biosciences American Depositary Shares shares in Q1 2024, an estimated $590K.
Schroder Investment Management Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 6 quarters.
Schroder Investment Management Group's NovaBridge Biosciences American Depositary Shares position peaked at $2.7M in Q2 2022.
39 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2024.

Based on Schroder Investment Management Group's 13F filing for Q1 2024, filed 14 May 2024.